Duration of Adjuvant Trastuzumab for HER2-Positive Breast Cancer | NobleID

Knowledge Graph Citation Graph Docs

Main

Mint Work Search Explore Works Knowledge Graph Citation Graph Bibliometrics Receipts

v1

Duration of Adjuvant Trastuzumab for HER2-Positive Breast Cancer

Identifier:nobleid.org/w1/20260515/AF3DBB75

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AF3DBB75.svg?ark=w1%2F20260515%2FAF3DBB75)](https://nobleid.org/work/w1/20260515/AF3DBB75)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

William J. Gradishar

Claim authorship of this work

info@nobleid.org

About Terms Policy Persistence & Resolver Service Policy Pricing